Neoplasms, Connective and Soft Tissue: Clinical Trials

3786 trials for Neoplasms, Connective and Soft Tissue, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1769 completed, 604 recruiting, 443 unknown, 393 terminated. 1402 Phase 2, 898 Phase 1, 591 Not applicable, 313 Phase 3, 97 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21402Completed 672, Recruiting 205, Terminated 167, Unknown 150, Active not recruiting 113, Not yet recruiting 45, Withdrawn 41, Suspended 7, Enrolling by invitation 2
Phase 1898Completed 432, Recruiting 157, Terminated 130, Active not recruiting 66, Unknown 49, Withdrawn 35, Not yet recruiting 19, Suspended 7, Enrolling by invitation 3
Not applicable591Completed 245, Recruiting 105, Unknown 102, Terminated 42, Not yet recruiting 37, Active not recruiting 31, Withdrawn 24, Enrolling by invitation 4, Suspended 1
Phase 3313Completed 163, Terminated 42, Unknown 38, Recruiting 29, Active not recruiting 23, Withdrawn 11, Not yet recruiting 6, Suspended 1
Phase 497Completed 47, Unknown 19, Terminated 10, Recruiting 9, Active not recruiting 6, Not yet recruiting 3, Withdrawn 2, Enrolling by invitation 1
Early Phase 160Completed 16, Unknown 12, Active not recruiting 9, Recruiting 7, Terminated 7, Not yet recruiting 5, Withdrawn 4

Follow this condition Literature Review of Neoplasms, Connective and Soft Tissue trials Research Report on Neoplasms, Connective and Soft Tissue

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor
Pimicotinib, Tumor resection surgery - Tenosynovial Giant Cell Tumor, Diffuse
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine842027-10-012026-07-16
Combination Immunotherapy Targeting Sarcomas
Multiple sarcoma-specific CAR-T cells and sarcoma vaccines - Sarcoma, Osteoid Sarcoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute202027-07-012026-08-26
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Sarcoma-specific CAR-T cells - Sarcoma, Osteoid Sarcoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute202027-06-012026-08-26
A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat
Archive Sample Retrieval, Biospecimen Collection, pH Low Insertion Peptide-exatecan Conjugate CBX-12 - Recurrent Childhood Ewing Sarcoma, Recurrent Childhood Malignant Solid Neoplasm
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group792027-05-072026-09-22
Information-providing Chatbot
ASCC (sarcoma-specific AI chatbot), Routine Clinical Care - Sarcoma
Not applicableNot yet recruitingThe Hong Kong Polytechnic University782027-04-012026-04-01
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma
DT-7012, Doxorubicin - Undifferentiated Pleomorphic Sarcoma (UPS), Dedifferentiated Liposarcoma (DDLPS)
Phase 2Not yet recruitingGustave Roussy, Cancer Campus, Grand Paris802027-02-012026-09-15
RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT
LX-101 - Ewing Sarcoma
Phase 2Not yet recruitingM.D. Anderson Cancer Center1202027-02-012026-08-24
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
ST316 IV - Familial Adenomatous Polyposis (FAP)
Phase 1Not yet recruitingSapience Therapeutics402027-01-042026-08-12
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor)
Phase 2Not yet recruitingGirish Dhall, MD232027-01-012026-08-04
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
Whole body MRI - Sarcoma
Not applicableNot yet recruitingCliniques universitaires Saint-Luc- Université Catholique de Louvain1222027-01-012026-04-29
Hyperpolarized MRI for GIST on Imatinib
Hyperpolarized 13C-MRI - Imatinib Therapy Response, Gastrointestinal Stromal Tumor (GIST)
Not yet recruitingChang Gung Memorial Hospital302027-01-012026-07-24
Sarcoma and Intra-infusion Exercise for Better Outcomes
Exercise - Sarcoma
Not applicableNot yet recruitingKira Bloomquist162027-01-012026-08-25
Tumor-Lymph Node Mapping
ICG (Indocyanine Green) - Pediatric Solid Tumors, Rhabdomyosarcoma
Not yet recruitingUniversity of Rochester102026-12-132026-08-26
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Acupuncture - Febrile Neutropenia, Sarcoma
Not applicableNot yet recruitingShaare Zedek Medical Center602026-12-012026-04-29
Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer FAPI and Whole-body PET/MRI
FAPI tracer - Sarcoma
Phase 2Not yet recruitingCopenhagen University Hospital, Rigshospitalet402026-12-012026-10-06
Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Kidney Carcinoma, Advanced Renal Cell Carcinoma
Phase 1Not yet recruitingJonsson Comprehensive Cancer Center182026-12-012026-08-06
Treatment of Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies
Moonshot Antibodies - Soft Tissue Cancer
Phase 1Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)162026-12-012026-09-22
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Doxorubicin - Sarcoma
Phase 2RecruitingUniversity of Colorado, Denver202026-12-012026-02-05
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma
biopsy tract resection, biopsy tract non-resection - Primary, Sarcoma
Phase 2Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine33002026-12-012026-07-14

Showing 20 of 3786. Sign in to see all of them.

Narrower conditions

Sarcoma (1602)  ·  Osteosarcoma (469)  ·  Leiomyoma (422)  ·  Gastrointestinal Stromal Tumors (335)  ·  Neoplasms (255)  ·  Ovarian Neoplasms (248)  ·  Sarcoma, Ewing (244)  ·  Rhabdomyosarcoma (229)  ·  Breast Neoplasms (220)  ·  Melanoma (218)  ·  Neuroblastoma (207)  ·  Liposarcoma (158)  ·  Leiomyosarcoma (157)  ·  Sarcoma, Kaposi (154)  ·  Neoplasm Metastasis (147)

Broader conditions

Neoplasms by Histologic Type (3777)  ·  Neoplasms (3531)  ·  Neoplasms, Connective Tissue (1723)  ·  Neoplasms by Site (1074)  ·  Sarcoma (873)  ·  Neoplasms, Muscle Tissue (852)  ·  Urogenital Diseases (839)  ·  Neoplasms, Glandular and Epithelial (734)  ·  Female Urogenital Diseases and Pregnancy Complications (729)  ·  Female Urogenital Diseases (724)  ·  Digestive System Diseases (675)  ·  Skin and Connective Tissue Diseases (662)  ·  Genital Diseases (659)  ·  Digestive System Neoplasms (646)

Interventions

Doxorubicin (193)  ·  Cyclophosphamide (131)  ·  Ifosfamide (114)  ·  Radiotherapy (110)  ·  Imatinib Mesylate (91)  ·  Gemcitabine (89)  ·  Vincristine (70)  ·  Cisplatin (69)  ·  Filgrastim (69)  ·  Etoposide (66)  ·  Carboplatin (63)  ·  pembrolizumab (63)  ·  Paclitaxel (61)  ·  Magnetic Resonance Spectroscopy (60)  ·  Irinotecan (57)

Sponsors

National Cancer Institute (NCI) (242)  ·  Memorial Sloan Kettering Cancer Center (91)  ·  M.D. Anderson Cancer Center (89)  ·  Children's Oncology Group (76)  ·  Novartis Pharmaceuticals (48)  ·  Peking University People's Hospital (41)  ·  Mayo Clinic (37)  ·  Gynecologic Oncology Group (33)  ·  European Organisation for Research and Treatment of Cancer - EORTC (32)  ·  Istituto Ortopedico Rizzoli (32)  ·  Dana-Farber Cancer Institute (31)  ·  St. Jude Children's Research Hospital (31)  ·  Centre Leon Berard (27)  ·  Institut Bergonié (27)  ·  Washington University School of Medicine (27)

Countries

United States (1963)  ·  France (400)  ·  China (353)  ·  Canada (305)  ·  Italy (294)  ·  United Kingdom (249)  ·  Germany (241)  ·  Spain (211)  ·  Netherlands (177)  ·  Australia (168)  ·  Belgium (141)  ·  South Korea (127)  ·  Poland (105)  ·  Switzerland (84)  ·  Japan (83)

Top investigators

Robert Yarchoan, M.D. (10)  ·  Suzanne George, MD (9)  ·  Brigitte C Widemann, M.D. (8)  ·  Robert Maki, MD, PhD (8)  ·  Sandra D'Angelo, MD (8)  ·  Seth Pollack (8)  ·  AeRang Kim, MD, PhD (7)

Results publications

PMID 31401903, PMID 32827353, PMID 37185961, PMID 22682017, PMID 30274985, PMID 35115306, PMID 36357960, PMID 38603649, PMID 17046465, PMID 21345435, PMID 21826194, PMID 28391775, PMID 31553693, PMID 31971678, PMID 32615108, PMID 33465704, PMID 33596357, PMID 34878624, PMID 35790816, PMID 37477173, PMID 37863160, PMID 40341199, PMID 11323136, PMID 12094370, PMID 14645423, PMID 16000093, PMID 16624552, PMID 17290061, PMID 17822748, PMID 18076015, PMID 18378136, PMID 18774375, PMID 19451433, PMID 19556464, PMID 19949018, PMID 21134978, PMID 21387287, PMID 21410393, PMID 21613624, PMID 21941283, PMID 22002018, PMID 23177515, PMID 23188490, PMID 23450030, PMID 24444087, PMID 24504442, PMID 24618336, PMID 24630081, PMID 25209242, PMID 25421877

NIH funding

U10CA180886 (33), U10CA098543 (30), 2015 (22), 2016 (22), U10CA027469 (19), 2023 (18), U10CA180868 (16), 2017 (15), 2018 (15), 2009 (13), P30CA015704 (13), U10CA032102 (13), P30CA033572 (11), 2014 (10), 2025 (10)